Cargando…

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders

Detalles Bibliográficos
Autores principales:	Blest-Hopley, Grace, Amit, Ben H., O'Neill, Aisling, Ruffell, Simon G. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214950/ https://www.ncbi.nlm.nih.gov/pubmed/37252138 http://dx.doi.org/10.3389/fpsyt.2023.1191970

Ejemplares similares

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

T99. LONG-TERM CANNABIS USE ASSOCIATED WITH ALTERED FUNCTIONING DURING VERBAL LEARNING
por: Blest-Hopley, Grace, et al.
Publicado: (2018)

O5.2. CBD MODULATION OF HIPPOCAMPAL GLUTAMATE IN PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2020)

Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use
por: Blest-Hopley, Grace, et al.
Publicado: (2019)

S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2018)

Cannabidiol modulation of hippocampal glutamate in early psychosis
por: O’Neill, Aisling, et al.
Publicado: (2021)

Prospects for the Use of Cannabinoids in Psychiatric Disorders
por: Graczyk, Michał, et al.
Publicado: (2021)

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021)

Psychedelics and workplace harm
por: Viña, Sean Matthew, et al.
Publicado: (2023)

Editorial: Current challenges and evidence-based medicine in psychiatric emergencies
por: Baldaçara, Leonardo
Publicado: (2023)

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
por: Kurtz, Joshua S, et al.
Publicado: (2022)

Commentary: Psychedelic Psychiatry's Brave New World
por: Nobile, Bénédicte, et al.
Publicado: (2020)

Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021)

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
por: Page, Lisa A., et al.
Publicado: (2021)

Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis
por: Murphy, Felim, et al.
Publicado: (2022)

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
por: Barnett, Brian S., et al.
Publicado: (2023)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
por: Langlitz, Nicolas, et al.
Publicado: (2021)

How Psychedelic-Assisted Treatment Works in the Bayesian Brain
por: Villiger, Daniel
Publicado: (2022)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022)

The economics of psychedelic-assisted therapies: A research agenda
por: Marseille, Elliot, et al.
Publicado: (2022)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
por: Mosurinjohn, Sharday, et al.
Publicado: (2023)

Medical student attitudes and perceptions of psychedelic-assisted therapies
por: Li, Irene, et al.
Publicado: (2023)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
por: Potvin, Stéphane, et al.
Publicado: (2020)

Regular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: Results from a complementary meta-analysis
por: Blest-Hopley, Grace, et al.
Publicado: (2019)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
por: Close, James B., et al.
Publicado: (2021)

Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States
por: Avram, Mihai, et al.
Publicado: (2021)

Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience
por: Neuhaus, Edmund C., et al.
Publicado: (2022)

Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
por: Mintz, Kevin T., et al.
Publicado: (2022)

Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity
por: Fischman, Lawrence G.
Publicado: (2022)

Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
por: Ko, Kwonmok, et al.
Publicado: (2022)

Classic psychedelics do not affect T cell and monocyte immune responses
por: Rudin, Deborah, et al.
Publicado: (2023)

Editorial: Psychomotor Symptomatology in Psychiatric Illnesses
por: Walther, Sebastian, et al.
Publicado: (2015)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Editorial: Novel Technology in Psychiatric Rehabilitation
por: Tsang, Hector W. H., et al.
Publicado: (2022)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_che43aj1eq5c7vlboffi8git1o